article thumbnail

GSK's ViiV explores novel pathway to bring long-acting HIV med Cabenuva to tough-to-treat patients

Fierce Pharma

GSK’s Cabenuva made history in 2020 as the world’s firs | GSK's long-acting Cabenuva is currently approved only as a switch therapy for patients who already have undetectable HIV levels in the blood. Trying to reach some tough populations who have difficulty adhering to existing daily oral therapies, GSK is getting creative.

Patients 273
article thumbnail

WebMD Bolsters Patient Engagement Offerings Through New Acquisition

MedCity News

WebMD acquired the operating assets of Healthwise, a nonprofit provider of health education content and patient engagement tools. The deal follows another acquisition WebMD made in the patient engagement space in 2020.

Patients 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Top 10 Medical Device Success Podcasts in 2020!

Medical Device Success

35 podcasts were produced in our inaugural year of 2020. 1 Ep 4 – The Future of the Medical Device Industry in the Covid-19 Era, April 12, 2020. 2 Ep 6 – Selling in a Covid-19 Word – New Sales Practices, April 26, 2020. 3 Ep 10 – The Reopening, Covid-19 and what it means for Medical Devices, May 24, 2020.

Medical 100
article thumbnail

PanAgora Pharma: Pharma Action in Patient Advocacy Summit December 2020

Pharma Marketing Network

PanAgora Pharma: Pharma Action in Patient Advocacy Summit | December 2020. ACTIONABLE INSIGHTS TO DRIVE PARTNERSHIPS BETWEEN PHARMA AND PATIENTS. The Pharma Action in Patient Advocacy Summit 2020 focuses on how pharma can use technology, data, and design to drive patient engagement and outcomes in a real and measurable way.

Pharma 52
article thumbnail

Do patients care about accelerated approval drugs?

World of DTC Marketing

Do patients care? Do patients care? 85% of accelerated approvals from 2010 to 2020 were for oncology indications. If you’re a cancer patient and your oncologist is prescribing a drug approved via accelerated Approval, are you going to refuse treatment? The post Do patients care about accelerated approval drugs?

Patients 200
article thumbnail

3 Insights From Re:Imagine Pharma Marketing 2020

Pharma Marketing Network

Re:Imagine Pharma Marketing: How Pharma Marketing is Evolving in 2020. On November 9-11, 2020, Imagine Pharma Marketing held a virtual conference that discussed the roadmap for embedding long term commercial evolution in marketing. Pharma Marketing 2020: The Enduring Impact .

article thumbnail

Endometriosis market projected to grow at a CAGR of 10% between 2020 and 2030

Pharmaceutical Technology

The endometriosis market is expected to grow from $1.05bn in 2020 to $2.72bn in 2030 at a compound annual growth rate (CAGR) of 10.0% GnRH antagonists have an improved safety and efficacy profile compared to the marketed GnRH agonists, which have significant side effects that are unappealing to patients. of 7MM sales.